Lightweight Human Trem2(triggering Receptor Expressed On Myeloid Cells 2) Elisa Kit Series [D7ApFRUw]

Human TREM2 ELISA Kit

The Human TREM2 (Triggering Receptor Expressed On Myeloid Cells 2) ELISA Kit is a high-quality diagnostic tool designed for quantitative measurement of TREM2 in human serum, plasma, cell culture supernatants, and urine. This kit is ideal for researchers and healthcare professionals seeking a reliable and efficient method to assess TREM2 levels in various biological samples. The kit offers exceptional sensitivity and specificity, ensuring accurate and reproducible results.

• High Sensitivity: Detects low levels of TREM2 with high accuracy.
• Specificity: Minimizes cross-reactivity with other proteins, ensuring reliable results.
• Easy to Use: Follows a simple and straightforward protocol for convenient and efficient testing.

Product Properties and Specifications

This ELISA kit is developed using a sandwich enzyme-linked immunosorbent assay (ELISA) technique, which allows for the detection of TREM2 with exceptional sensitivity. The kit includes all necessary reagents, including antibodies, buffers, and enzymes, ensuring a complete and hassle-free testing experience. The kit has a detection range of 7.8 pg/mL to 500 pg/mL, making it suitable for a wide range of applications.

• Assay Format: Sandwich ELISA
• Assay Range: 7.8 pg/mL to 500 pg/mL
• Sample Types: Serum, plasma, cell culture supernatants, urine

Practical Uses and Benefits

The Human TREM2 ELISA Kit is a valuable tool for researchers studying neurodegenerative diseases, inflammation, and immune responses. It is also suitable for clinical diagnostics, helping healthcare professionals identify and monitor patients with TREM2-related conditions. The kit's high sensitivity and specificity make it an essential tool for accurate and timely diagnosis, contributing to improved patient care and treatment outcomes.

• Research Applications: Neurodegenerative diseases, inflammation, immune responses
• Clinical Diagnostics: Identification and monitoring of TREM2-related conditions
• Improved Patient Care: Accurate and timely diagnosis for better treatment outcomes